Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Department of Histology and Embryology, School of Medicine, University of Athens, Athens 11527, Greece.
Cancer Cell. 2014 Apr 14;25(4):484-500. doi: 10.1016/j.ccr.2014.02.019. Epub 2014 Mar 27.
Colorectal cancer is frequently associated with chronic inflammation, with the intestinal epithelial barrier playing an important protective role against the infections and injuries that cause colitis. The p38α pathway regulates inflammatory responses but can also suppress tumor initiation in epithelial cells. We have found that p38α signaling has a dual function in colorectal tumorigenesis. On one side, p38α protects intestinal epithelial cells against colitis-associated colon cancer by regulating intestinal epithelial barrier function. Accordingly, p38α downregulation results in enhanced colitis-induced epithelial damage and inflammation, which potentiates colon tumor formation. Surprisingly, inhibition of p38α in transformed colon epithelial cells reduces tumor burden. Thus, p38α suppresses inflammation-associated epithelial damage and tumorigenesis but contributes to the proliferation and survival of tumor cells.
结直肠癌常与慢性炎症相关,肠道上皮屏障在防止引起结肠炎的感染和损伤方面发挥着重要的保护作用。p38α 途径调节炎症反应,但也可以抑制上皮细胞中的肿瘤起始。我们发现 p38α 信号在结直肠肿瘤发生中具有双重作用。一方面,p38α 通过调节肠道上皮屏障功能来保护肠道上皮细胞免受结肠炎相关结肠癌的侵害。因此,p38α 的下调会导致增强的结肠炎诱导的上皮损伤和炎症,从而促进结肠肿瘤的形成。令人惊讶的是,转化的结肠上皮细胞中 p38α 的抑制会降低肿瘤负担。因此,p38α 抑制炎症相关的上皮损伤和肿瘤发生,但促进肿瘤细胞的增殖和存活。